Mirikizumab - SC clinical trials

Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

This study looks at how well a medicine called mirikizumab helps people with Crohn's disease. It's for adults aged 18-75 who have active Crohn's, focusing on healing the bowel lining. The aim is to see if the treatment can make the bowel look normal inside on scans.